Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 370.05
+9.85 (2.73%)
At close: Jun 16, 2026
Gufic Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 37,110 | 27,533 | 33,738 | 28,394 | 18,095 | 24,129 | |
Market Cap Growth | -3.44% | -18.39% | 18.82% | 56.92% | -25.01% | 171.24% |
Enterprise Value | 40,395 | 30,344 | 36,504 | 31,818 | 19,487 | 23,753 |
Last Close Price | 370.05 | 274.55 | 336.36 | 283.00 | 186.49 | 248.56 |
PE Ratio | 57.82 | 42.88 | 48.44 | 32.96 | 22.70 | 25.18 |
PS Ratio | 3.93 | 2.92 | 4.12 | 3.52 | 2.62 | 3.10 |
PB Ratio | 5.58 | 4.14 | 5.61 | 5.33 | 5.20 | 8.97 |
P/TBV Ratio | 5.63 | 4.18 | 5.67 | 5.39 | 5.21 | 8.99 |
P/FCF Ratio | 269.17 | 199.71 | 71.72 | - | - | 128.44 |
P/OCF Ratio | 82.52 | 61.23 | 27.53 | - | - | 22.71 |
EV/Sales Ratio | 4.28 | 3.21 | 4.45 | 3.94 | 2.82 | 3.05 |
EV/EBITDA Ratio | 26.69 | 20.05 | 27.87 | 22.37 | 14.91 | 16.61 |
EV/EBIT Ratio | 33.52 | 25.18 | 31.11 | 24.00 | 16.90 | 18.40 |
EV/FCF Ratio | 293.00 | 220.10 | 77.60 | - | - | 126.44 |
Debt / Equity Ratio | 0.61 | 0.61 | 0.56 | 0.63 | 0.96 | 0.24 |
Debt / EBITDA Ratio | 2.67 | 2.67 | 2.44 | 2.23 | 2.43 | 0.44 |
Debt / FCF Ratio | 29.36 | 29.36 | 7.15 | - | - | 3.43 |
Net Debt / Equity Ratio | 0.49 | 0.49 | 0.53 | 0.62 | 0.88 | 0.20 |
Net Debt / EBITDA Ratio | 2.17 | 2.17 | 2.45 | 2.33 | 2.34 | 0.37 |
Net Debt / FCF Ratio | 23.83 | 23.83 | 6.81 | -2.76 | -1.43 | 2.81 |
Asset Turnover | 0.75 | 0.75 | 0.73 | 0.83 | 1.00 | 1.71 |
Inventory Turnover | 1.56 | 1.56 | 1.83 | 2.08 | 2.27 | 4.01 |
Quick Ratio | 0.73 | 0.73 | 0.86 | 0.89 | 0.81 | 0.88 |
Current Ratio | 1.55 | 1.55 | 1.61 | 1.61 | 1.61 | 1.72 |
Return on Equity (ROE) | 10.14% | 10.14% | 12.29% | 19.57% | 25.84% | 43.31% |
Return on Assets (ROA) | 6.00% | 6.00% | 6.48% | 8.48% | 10.43% | 17.67% |
Return on Invested Capital (ROIC) | 9.38% | 9.34% | 9.72% | 13.01% | 17.66% | 35.43% |
Return on Capital Employed (ROCE) | 14.60% | 14.60% | 15.00% | 18.40% | 20.10% | 38.50% |
Earnings Yield | 1.73% | 2.33% | 2.06% | 3.03% | 4.41% | 3.97% |
FCF Yield | 0.37% | 0.50% | 1.39% | -4.23% | -11.84% | 0.78% |
Dividend Yield | 0.03% | 0.04% | 0.03% | 0.03% | 0.05% | 0.04% |
Payout Ratio | 1.56% | 1.56% | 1.44% | 1.13% | 1.31% | 0.96% |
Buyback Yield / Dilution | -0.06% | -0.06% | -1.78% | -1.63% | - | - |
Total Shareholder Return | -0.03% | -0.02% | -1.75% | -1.59% | 0.05% | 0.04% |